Trial Parameters
Condition Bladder Cancer
Sponsor Assiut University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 58
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2025-12-01
Completion 2026-07-01
Interventions
Gadolinium
Brief Summary
Our aim in this prospective study is to evaluate the validity of the non-contrast biparametric MRI (bp-MRI), including T2-WI and DWI sequences, and the availability of an alternative to the mp-MRI, for the muscle invasiveness assessment of bladder cancer using VIRAD scoring in both techniques.
Eligibility Criteria
Inclusion Criteria: 58 cases of patients who suspected to have cancer urinary bladder by clinical, histopathological examination and radiological imaging. All age groups . Both sex Exclusion Criteria: patient with high renal chemistry. Patient with contraindications to MRI as pacemaker and cochlear implants. \-
Related Trials
NCT07324798
Adaptive Radiotherapy for Genitourinary Cancers
View Trial →
NCT06973161
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
View Trial →
NCT07339761
Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
View Trial →